KRKA: Unaudited interim report of the Krka Group and the Krka, d. d., Novo mesto for the first quarter of 2022

2022-05-19 08:15

publikacja
2022-05-19 08:15

Spis treści:

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
Unaudited_interim_report_of_the_Krka_Group_and_the_Krka,_d._d.,_Novo_mesto_for_the_first_quarter_2022_.pdf (REPORT)
Press_release.pdf (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
		UNI - EN REPORT No		9	/	2022
Date of issue:	2022-05-19
Short name of the issuer
KRKA
Subject
Unaudited interim report of the Krka Group and the Krka, d. d., Novo mesto for the first quarter of 2022
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Based on Article 26 of the Rules of the Ljubljana Stock Exchange d.d. company Krka, d. d., Novo mesto publishes the Unaudited interim report of the Krka Group and Krka, d. d., Novo mesto for the first quarter of 2022.The report will be published on the Company's website www.krka.biz from 19 May 2022 onwards, for a period of at least 5 years
Annexes
File			Description
Unaudited interim report of the Krka Group and the Krka, d. d., Novo mesto for the first quarter 2022 .pdfUnaudited interim report of the Krka Group and the Krka, d. d., Novo mesto for the first quarter 2022 .pdf			Unaudited interim report of the Krka Group and the Krka, d. d., Novo mesto for the first quarter 2022
Press release.pdfPress release.pdf			Press release

KRKA, TOVARNA ZDRAVIL D.D.

(fullname of the issuer)

KRKA

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification
of the WSE in Warsow)

8501

Nove Mesto

(post code)

(city)

Smarjeska

(street)

(number)

+386 7 331 21 11

+386 7 332 15 37

(phone number)

(fax)

(e-mail)

(web site)

nie dotyczy

(NIP)

(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date	Name	Position / Function	Signature
2022-05-19	Jože Colarič	President of the management board and CEO

Ważne linki